✦ LIBER ✦

Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growth

✍ Scribed by Bajou, Khalid; Maillard, Catherine; Jost, Maud; Lijnen, Roger H; Gils, Ann; Declerck, Paul; Carmeliet, Peter; Foidart, Jean-Michel; Noel, Agnès

Book ID: 110068927
Publisher: Nature Publishing Group
Year: 2004
Tongue: English
Weight: 194 KB
Volume: 23
Category: Article
ISSN: 0950-9232
DOI: 10.1038/sj.onc.1207859

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Periodicity in the levels of serum plasm

Periodicity in the levels of serum plasminogen activator inhibitor-1 (PAI-1) is a robust prognostic factor for embryo implantation and clinical pregnancy outcome in conventional IVF cycles

✍ Mehta, B.N.; Nath, N.M.; Chimote, N.N.; Chimote, N.M. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Plasminogen activator inhibitor-2 is exp

Plasminogen activator inhibitor-2 is expressed in different types of congenital ichthyosis: in vivo evidence for its cross-linking into the cornified cell envelope by transglutaminase-1

✍ V. Oji; M.E. Oji; N. Adamini; T. Walker; K. Aufenvenne; M. Raghunath; H. Traupe 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 852 KB

Plasminogen Activator Inhibitor 1 Expres

Plasminogen Activator Inhibitor 1 Expression is Regulated by the Inflammatory Mediators Interleukin-1α, Tumor Necrosis Factor-α, Transforming Growth Factor-β and Oncostatin M in Human Cardiac Myocytes

✍ Karin Macfelda; Thomas W. Weiss; Christoph Kaun; Johannes M. Breuss; Gerlinde Zo 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 436 KB

Dedifferentiation of serous ovarian canc

Dedifferentiation of serous ovarian cancer from cystic to solid tumors is associated with increased expression of mRNA for urokinase plasminogen activator (uPA), its receptor (uPAR) and its inhibitor (PAI-1)

✍ Christer Borgfeldt; Stefan R. Hansson; Barbro Gustavsson; Anna Måsbäck; Bertil C 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 337 KB 👁 1 views

The plasminogen activating system is involved in tumor growth and metastasis by degradation of extracellular matrix, and modulation of cell adhesion and migration. Benign and well-differentiated malignant ovarian tumors present as cystic lesions with preserved glandular morphology, whereas poorly di

Urokinase-type plasminogen activator (uP

Urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 for tumor-biological risk assessment in node-negative breast cancer patients – The multicenter trial NNBC 3-Europe

✍ C. Thomssen; M. Vetter; D. Paepke; M. Schmidt; C. Veyret; D. Augustin; V. Hanf; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 75 KB